165 related articles for article (PubMed ID: 23981141)
1. Clinical features and predictors of clinical outcomes in Korean patients with Crohn's disease: a Korean association for the study of intestinal diseases multicenter study.
Moon CM; Park DI; Kim ER; Kim YH; Lee CK; Lee SH; Kim JH; Huh KC; Jung SA; Yoon SM; Song HJ; Jang HJ; Kim YS; Lee KM; Shin JE
J Gastroenterol Hepatol; 2014 Jan; 29(1):74-82. PubMed ID: 23981141
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic features of Crohn's disease associated with failure of medical treatment.
Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
[TBL] [Abstract][Full Text] [Related]
3. Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease.
Qiu Y; Chen BL; Feng R; Zhang SH; He Y; Zeng ZR; Ben-Horin S; Peyrin-Biroulet L; Mao R; Chen MH
J Gastroenterol Hepatol; 2018 Mar; 33(3):664-670. PubMed ID: 28940780
[TBL] [Abstract][Full Text] [Related]
4. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.
Lakatos PL; Czegledi Z; Szamosi T; Banai J; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp J; Lakatos L
World J Gastroenterol; 2009 Jul; 15(28):3504-10. PubMed ID: 19630105
[TBL] [Abstract][Full Text] [Related]
5. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
6. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
Chhaya V; Saxena S; Cecil E; Subramanian V; Curcin V; Majeed A; Pollok RC
Inflamm Bowel Dis; 2015 Feb; 21(2):385-91. PubMed ID: 25569740
[TBL] [Abstract][Full Text] [Related]
7. Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study.
Hwang SW; Kim JH; Im JP; Ye BD; Koo HS; Huh KC; Cheon JH; Kim YS; Kim YH; Han DS; Kim WH; Kim JS;
J Gastroenterol Hepatol; 2017 Oct; 32(10):1716-1722. PubMed ID: 28251684
[TBL] [Abstract][Full Text] [Related]
8. Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents.
Guasch M; Cañete F; Ordás I; Iglesias-Flores E; Clos A; Gisbert JP; Taxonera C; Vera I; Mínguez M; Guardiola J; Rivero M; Nos P; Gomollón F; Barrio J; de Francisco R; López-Sanromán A; Martín-Arranz MD; Garcia-Planella E; Camargo R; García-López S; de Castro L; Calvet X; Esteve M; Mañosa M; Domènech E;
J Gastroenterol Hepatol; 2020 Dec; 35(12):2080-2087. PubMed ID: 32350906
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and long-term prognosis of perianal Crohn's disease in an Asian population.
Song EM; Lee HS; Kim YJ; Oh EH; Ham NS; Kim J; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
J Gastroenterol Hepatol; 2021 Jun; 36(6):1571-1579. PubMed ID: 33091187
[TBL] [Abstract][Full Text] [Related]
10. The changing face of Crohn's disease: a population-based study of the natural history of Crohn's disease in Örebro, Sweden 1963-2005.
Zhulina Y; Udumyan R; Tysk C; Montgomery S; Halfvarson J
Scand J Gastroenterol; 2016 Mar; 51(3):304-13. PubMed ID: 26448101
[TBL] [Abstract][Full Text] [Related]
11. Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry.
Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Langholff W; Londhe A; Sandborn WJ
Am J Gastroenterol; 2014 Feb; 109(2):212-23. PubMed ID: 24394749
[TBL] [Abstract][Full Text] [Related]
12. Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era.
Nunes T; Etchevers MJ; Domènech E; García-Sánchez V; Ber Y; Peñalva M; Merino O; Nos P; Garcia-Planella E; Casbas AG; Esteve M; Taxonera Samsó C; Montoro Huguet M; Gisbert JP; Martín Arranz MD; García-Sepulcre MF; Barreiro-de Acosta M; Beltrán B; Alcaide Suárez N; Saro Gismera C; Cabriada JL; Cañas-Ventura A; Gomollón F; Panés J;
Aliment Pharmacol Ther; 2013 Oct; 38(7):752-60. PubMed ID: 23980933
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.
Golovics PA; Lakatos L; Mandel MD; Lovasz BD; Vegh Z; Kurti Z; Szita I; Kiss LS; Pandur T; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(23):7272-80. PubMed ID: 26109815
[TBL] [Abstract][Full Text] [Related]
14. Changes of Crohn's disease phenotype over time.
Ouaz A; Fekih M; Labidi A; Ben Mustapha N; Serghini M; Zouiten L; Boubaker J; Filali A
Tunis Med; 2016 Jun; 94(6):167-170. PubMed ID: 28051217
[TBL] [Abstract][Full Text] [Related]
15. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
Kariyawasam VC; Selinger CP; Katelaris PH; Jones DB; McDonald C; Barr G; Chapman G; Colliwshaw J; Lunney PC; Middleton K; Wang RR; Huang T; Andrews J; Leong RW
Inflamm Bowel Dis; 2014 Aug; 20(8):1382-90. PubMed ID: 24991785
[TBL] [Abstract][Full Text] [Related]
16. Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn's disease: a ten-year hospital-based observational study in China.
Wang H; Wu Y; Ye C; Liu Z; Wang X
BMC Gastroenterol; 2021 Oct; 21(1):376. PubMed ID: 34649523
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
[TBL] [Abstract][Full Text] [Related]
18. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
[TBL] [Abstract][Full Text] [Related]
19. Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn's disease patients from a population-based cohort.
Nasir BF; Griffiths L; Nasir A; Roberts R; Barclay M; Gearry R; Lea RA
J Clin Gastroenterol; 2013 Mar; 47(3):242-5. PubMed ID: 22739221
[TBL] [Abstract][Full Text] [Related]
20. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
